Live Breaking News & Updates on Prnewswire The Company Nasdaq

Stay updated with breaking news from Prnewswire the company nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization. ....

United States , Hong Kong , South Korea , Lin Shen , San Diego , Gigi Feng , Andrew Zhu , Richard Yeh , Prnewswire The Company Nasdaq , Cancer Hospital Of Peking University , Exchange Commission , Drug Administration , Lifelink Oncology Research Institute , Clinical Oncology , Beijing Cancer Hospital , Peking University , Link Oncology Research , Orphan Drug Designation , Private Securities Litigation Reform Act , Operating Officer , Chief Financial , I Mab ,

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023

- Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation of patients immune system against cancer cells.. ....

United States , Hong Kong , Qing Zhou , Long Wu , San Diego , Andrew Zhu , Richard Yeh , Gigi Feng , Guangdong Academy Of Medical Sciences , Exchange Commission , Prnewswire The Company Nasdaq , Guangdong Lung Cancer Institute , American Society Of Clinical Oncology , Clinical Oncology , Principal Investigator , Guangdong Provincial People , Guangdong Academy , Medical Sciences , Guangdong Lung Cancer , Toripalimab Combination Therapy , Trial Results Using , Potential Predictive Biomarker , Private Securities Litigation Reform Act , Operating Officer , Chief Financial , I Mab ,

I-Mab Announces Poster Presentation of Proprietary CD73 Antibody Uliledlimab at ASCO 2023

/PRNewswire/ I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization. ....

United States , Qing Zhou , Hong Kong , San Diego , Mccormick Place , Gigi Feng , Richard Yeh , Exchange Commission , Mccormick Place Convention Center , Prnewswire The Company Nasdaq , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting , Toripalimab Combination Therapy , Trial Results Using , Potential Predictive , Guangdong Provincial People , Private Securities Litigation Reform Act , Operating Officer , Chief Financial , I Mab ,

I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon

Award is an important victory for I-Mab and its shareholders on multiple levels, ending the multi-year long dispute Tribunal completely denied Tracon s. ....

San Diego , United States , Hong Kong , Richard Yeh , Gigi Feng , Michael Sitrick Los Angeles , Andrew Zhu , Exchange Commission , Prnewswire The Company Nasdaq , Pharmaceuticals Tracon , Bsab Agreement , Securities Litigation Reform Act , Operating Officer , Chief Financial , Los Angeles , New York , I Mab ,

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022

Strategic reprioritization of the Company s pipeline to focus on key clinical assets and overall streamlining of corporate structure and workforce, resulting. ....

South Korea , San Diego , United States , Hong Kong , Gigi Feng , Andrew Zhu , Richard Yeh , Genexine Neoimmunetech , Jingwu Zang , Corporate Development , Holding Foreign Companies Accountable , Company Responses To Recent , Company American Depositary , Holding Foreign Companies Accountable Act , Pipeline Development , European Society For Medical Oncology , Us Public Company Accounting Oversight Board , Henan Charity , Women Leadership Council , Research Development Expenses , Tracon Pharmaceuticals , Exchange Rate Information , Morgan Stanley Capital International , American Society Of Clinical Oncology , Exchange Commission , Prnewswire The Company Nasdaq ,